111 related articles for article (PubMed ID: 17486635)
1. Identification of novel Runx2 targets in osteoblasts: cell type-specific BMP-dependent regulation of Tram2.
Pregizer S; Barski A; Gersbach CA; García AJ; Frenkel B
J Cell Biochem; 2007 Dec; 102(6):1458-71. PubMed ID: 17486635
[TBL] [Abstract][Full Text] [Related]
2. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
3. Icariin induces osteogenic differentiation in vitro in a BMP- and Runx2-dependent manner.
Zhao J; Ohba S; Shinkai M; Chung UI; Nagamune T
Biochem Biophys Res Commun; 2008 May; 369(2):444-8. PubMed ID: 18295595
[TBL] [Abstract][Full Text] [Related]
4. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
Gu K; Zhang L; Jin T; Rutherford RB
Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of Runx2/Cbfa1-null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation.
Bae JS; Gutierrez S; Narla R; Pratap J; Devados R; van Wijnen AJ; Stein JL; Stein GS; Lian JB; Javed A
J Cell Biochem; 2007 Feb; 100(2):434-49. PubMed ID: 16927309
[TBL] [Abstract][Full Text] [Related]
7. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo osteoblastic differentiation of BMP-2- and Runx2-engineered skeletal myoblasts.
Gersbach CA; Guldberg RE; García AJ
J Cell Biochem; 2007 Apr; 100(5):1324-36. PubMed ID: 17131362
[TBL] [Abstract][Full Text] [Related]
9. Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation.
Wagley Y; Chesi A; Acevedo PK; Lu S; Wells AD; Johnson ME; Grant SFA; Hankenson KD
Stem Cells; 2020 Oct; 38(10):1332-1347. PubMed ID: 32535942
[TBL] [Abstract][Full Text] [Related]
10. Linarin promotes osteogenic differentiation by activating the BMP-2/RUNX2 pathway via protein kinase A signaling.
Li J; Hao L; Wu J; Zhang J; Su J
Int J Mol Med; 2016 Apr; 37(4):901-10. PubMed ID: 26935542
[TBL] [Abstract][Full Text] [Related]
11. Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
Kawane T; Komori H; Liu W; Moriishi T; Miyazaki T; Mori M; Matsuo Y; Takada Y; Izumi S; Jiang Q; Nishimura R; Kawai Y; Komori T
J Bone Miner Res; 2014 Sep; 29(9):1960-9. PubMed ID: 24692107
[TBL] [Abstract][Full Text] [Related]
12. Acerogenin A, a natural compound isolated from Acer nikoense Maxim, stimulates osteoblast differentiation through bone morphogenetic protein action.
Kihara T; Ichikawa S; Yonezawa T; Lee JW; Akihisa T; Woo JT; Michi Y; Amagasa T; Yamaguchi A
Biochem Biophys Res Commun; 2011 Mar; 406(2):211-7. PubMed ID: 21303661
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the upstream mouse Cbfa1/Runx2 promoter.
Xiao ZS; Liu SG; Hinson TK; Quarles LD
J Cell Biochem; 2001; 82(4):647-59. PubMed ID: 11500942
[TBL] [Abstract][Full Text] [Related]
15. RUNX2 Regulates Osteoblast Differentiation via the BMP4 Signaling Pathway.
Liu DD; Zhang CY; Liu Y; Li J; Wang YX; Zheng SG
J Dent Res; 2022 Sep; 101(10):1227-1237. PubMed ID: 35619284
[TBL] [Abstract][Full Text] [Related]
16. MAP Kinase-Dependent RUNX2 Phosphorylation Is Necessary for Epigenetic Modification of Chromatin During Osteoblast Differentiation.
Li Y; Ge C; Franceschi RT
J Cell Physiol; 2017 Sep; 232(9):2427-2435. PubMed ID: 27514023
[TBL] [Abstract][Full Text] [Related]
17. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation.
Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY
J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770
[TBL] [Abstract][Full Text] [Related]
18. deltaEF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineage.
Yang S; Zhao L; Yang J; Chai D; Zhang M; Zhang J; Ji X; Zhu T
J Biomed Sci; 2007 Sep; 14(5):663-79. PubMed ID: 17479358
[TBL] [Abstract][Full Text] [Related]
19. TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway.
Guo J; Qin W; Xing Q; Gao M; Wei F; Song Z; Chen L; Lin Y; Gao X; Lin Z
J Cell Physiol; 2017 Nov; 232(11):3158-3169. PubMed ID: 28063228
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
